FDA Announces OMB Approval for Anthrax Remediation Information Collection

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information on the evaluation of long-term antibiotic therapy for individuals involved in anthrax remediation efforts, as required by the Paperwork Reduction Act of 1995.